New Vaccine For HIV, Aids | Aids Medicines | Lenacapavir Injection | News In Focus | The Study IAS скачать в хорошем качестве

New Vaccine For HIV, Aids | Aids Medicines | Lenacapavir Injection | News In Focus | The Study IAS

📌 Talk to Manikant Sir's Team Course Enquiry Form: https://forms.gle/K7e4hg7SzYTkGV8d9 New Vaccine For HIV, Aids | Aids Medicines | Lenacapavir Injection | News In Focus | The Study IAS WHO has recommended Lenacapavir, a long-acting HIV prevention injection taken just twice a year. Announced at IAS 2025 in Kigali, this capsid inhibitor shows 99.9% efficacy, especially among high-risk groups. With FDA approval (as “Yeztugo”) and fewer adherence issues than daily PrEP pills, it could be a global game-changer. HIV continues to impact millions, but innovations like this offer hope. 🧬 Do you think India should adopt Lenacapavir widely? Share your views in the comments! 📌 Read important UPSC articles on our Blog: https://www.thestudyupsc.com/blogs/ 📌 Connect with us : Telegram Group: https://t.me/thestudyiasmanikantsir Whatsapp Channel: https://www.whatsapp.com/channel/0029... Instagram:   / thestudyias   Facebook:   / thestudyias   Twitter:   / thestudyias   Linkedin:   / thestudyias   📌 Download the App to Subscribe to our Courses - https://bit.ly/3ZL2RCG For any doubt, Call 7002070025 . . #hivsymptoms #aidssymptoms #lenacpavirinjection #injection #symptoms #medicine #vaccine #currentaffairs #manikantsir #news #thestudyias